Advertisement
AKTS vs ZBRA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a Buy and ZBRA is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AKTS’s FA Score shows that 0 FA rating(s) are green whileZBRA’s FA Score has 2 green FA rating(s).
- AKTS’s FA Score: 0 green, 5 red.
- ZBRA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AKTS’s TA Score shows that 6 TA indicator(s) are bullish while ZBRA’s TA Score has 4 bullish TA indicator(s).
- AKTS’s TA Score: 6 bullish, 3 bearish.
- ZBRA’s TA Score: 4 bullish, 4 bearish.
Price Growth
AKTS (@Biotechnology) experienced а +1.55% price change this week, while ZBRA (@Telecommunications Equipment) price change was -2.43% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -2.73%. For the same industry, the average monthly price growth was +9.11%, and the average quarterly price growth was +2529.75%.
The average weekly price growth across all stocks in the @Telecommunications Equipment industry was -4.25%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was +10.47%.
Reported Earning Dates
ZBRA is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (-2.73% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Telecommunications Equipment (-4.25% weekly)The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.
| AKTS | ZBRA | AKTS / ZBRA | |
| Capitalization | 1.44B | 16.6B | 9% |
| EBITDA | -76.75M | 884M | -9% |
| Gain YTD | N/A | 44.597 | - |
| P/E Ratio | N/A | 32.18 | - |
| Revenue | 8.28M | 5.58B | 0% |
| Total Cash | 538M | 114M | 472% |
| Total Debt | 11.6M | 2.85B | 0% |
AKTS | ZBRA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 74 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 49 | 100 | |
SMR RATING 1..100 | 95 | 65 | |
PRICE GROWTH RATING 1..100 | 40 | 7 | |
P/E GROWTH RATING 1..100 | 100 | 33 | |
SEASONALITY SCORE 1..100 | 11 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AKTS's Valuation (42) in the Telecommunications Equipment industry is in the same range as ZBRA (47) in the Computer Peripherals industry. This means that AKTS’s stock grew similarly to ZBRA’s over the last 12 months.
AKTS's Profit vs Risk Rating (49) in the Telecommunications Equipment industry is somewhat better than the same rating for ZBRA (100) in the Computer Peripherals industry. This means that AKTS’s stock grew somewhat faster than ZBRA’s over the last 12 months.
ZBRA's SMR Rating (65) in the Computer Peripherals industry is in the same range as AKTS (95) in the Telecommunications Equipment industry. This means that ZBRA’s stock grew similarly to AKTS’s over the last 12 months.
ZBRA's Price Growth Rating (7) in the Computer Peripherals industry is somewhat better than the same rating for AKTS (40) in the Telecommunications Equipment industry. This means that ZBRA’s stock grew somewhat faster than AKTS’s over the last 12 months.
ZBRA's P/E Growth Rating (33) in the Computer Peripherals industry is significantly better than the same rating for AKTS (100) in the Telecommunications Equipment industry. This means that ZBRA’s stock grew significantly faster than AKTS’s over the last 12 months.
| AKTS | ZBRA | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 87% |
| Stochastic ODDS (%) | 2 days ago 84% | 1 day ago 62% |
| Momentum ODDS (%) | 2 days ago 84% | 1 day ago 70% |
| MACD ODDS (%) | 2 days ago 90% | 1 day ago 72% |
| TrendWeek ODDS (%) | 2 days ago 90% | 1 day ago 70% |
| TrendMonth ODDS (%) | 2 days ago 81% | 1 day ago 66% |
| Advances ODDS (%) | 2 days ago 84% | 13 days ago 65% |
| Declines ODDS (%) | 6 days ago 90% | 2 days ago 72% |
| BollingerBands ODDS (%) | 2 days ago 85% | 1 day ago 76% |
| Aroon ODDS (%) | 2 days ago 76% | 1 day ago 68% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GTIP | 47.54 | N/A | +0.01% |
| Goldman Sachs Acs Infl Protd USD Bd ETF | |||
| LDRT | 24.90 | -0.02 | -0.08% |
| iShares iBonds 1-5 Year Treasury Ladder ETF | |||
| FMAR | 53.31 | -0.17 | -0.32% |
| FT Vest US Equity Buffer ETF Mar | |||
| BOUT | 43.85 | -0.28 | -0.63% |
| CapForce IBD® Breakout Opportunities ETF | |||
| FLEU | 36.04 | -0.41 | -1.13% |
| Franklin FTSE Eurozone ETF | |||